Providence Capital Advisors’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-43,509
| Closed | -$5.79M | – | 361 |
|
|
2024
Q1 | $5.79M | Buy |
43,509
+6,500
| +18% | +$865K | 1.26% | 32 |
|
|
2023
Q4 | $5.1M | Buy |
37,009
+1,400
| +4% | +$193K | 1.22% | 37 |
|
|
2023
Q3 | $4.34M | Buy |
35,609
+1,100
| +3% | +$134K | 1.14% | 43 |
|
|
2023
Q2 | $4.85M | Buy |
34,509
+3,894
| +13% | +$547K | 1.23% | 36 |
|
|
2023
Q1 | $4.33M | Buy |
30,615
+1,715
| +6% | +$243K | 1.14% | 47 |
|
|
2022
Q4 | $4.52M | Buy |
+28,900
| New | +$4.52M | 1.22% | 32 |
|
|
2020
Q2 | – | Sell |
-100
| Closed | -$8K | – | 208 |
|
|
2020
Q1 | $8K | Buy |
+100
| New | +$8K | ﹤0.01% | 182 |
|